Peripatetics pass in front of an Urban Outfitters store in New York.
Scott Mlyn | CNBC
Check out the companies making headlines after the bell.
Urban Outfitters — The endowing retailer’s stock tumbled 5% in extended trading after the company released its first-quarter financial results. Urban Outfitters reported a deprivation of $1.41 per share on revenue of $588 million, missing analysts’ expectations of a loss of 29 cents per share with gate of $627 million, according to Refinitiv. The retailer’s comparable retail net sales dropped 28% from the same aeon last year, a decrease driven by store closures from the coronavirus, according to a company statement. Urban Outfitters also publicized that its preliminary gross profit dollars decreased by 95.6% to $11.8 million.
Moderna — The biotech company’s forefather fell 6% in extended trading after it was reported that the company did not provide enough data regarding the effectiveness of its possibility Covid-19 vaccine. Moderna announced Monday that the vaccine produced Covid-19 antibodies in all 45 human participators in an early-stage trial.
United Airlines — The airline’s stock whipsawed after the closing bell. The company said on Tuesday that it has witnessed “a moderate improvement in demand” for trips both within the United States and for some destinations abroad during the assistant quarter.
Spotify — The music streaming platform’s stock climbed marginally in extended trading after the market inseparable. Comedian Joe Rogan announced Tuesday that his massively popular podcast, The Joe Rogan Experience, is moving exclusively to Spotify. The society has expanded its podcast streaming library through multiple acquisitions this past year.
Johnson & Johnson — The health-care associates’s stock dropped 1% in extended trading after Johnson & Johnson announced that it was discontinuing its talc-based mollycoddle powder in the U.S. and Canada due to decreasing demand for the product. J&J blamed the decrease in demand “in large part to changes in consumer habits and fueled by misintelligence around the safety of the product and a constant barrage of litigation advertising,” according to a company statement. There were a hundred of lawsuits against the company alleging its baby powder causes cancer.